JamesZBL/code-projects db-hospital-drug ShiroConfig.java improper authorization
Key facts
- Attack vector
- Network
- Privileges required
- Low
- User interaction
- None
- Attack complexity
- Low
- Attack requirements
- None
- Impact type
- Privilege escalation, Security bypass
- Confidentiality · integrity · availability
- Low · Low · Low
- Fix status
- No fix listed
Attack profile from CVSS 4.0 · CNA. Fix status from CNA. Impact type from CWE-266 and CWE-285.
Summary
A vulnerability was found in JamesZBL/code-projects db-hospital-drug 1.0 and classified as critical. Affected by this issue is some unknown functionality of the file ShiroConfig.java. The manipulation leads to improper authorization. The attack may be launched remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
Why it matters now
SSVC decision points
CISA ADP · SSVC 2.0.3
- Exploitation
- Poc
- Automatable
- No
- Technical impact
- Partial
The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.
Affected products
| Vendor | Product | Affected versions | Fixed in | Status | Source |
|---|---|---|---|---|---|
| JamesZBL | db-hospital-drug | 1.0 | — | No fix listed | CNA |
| code-projects | db-hospital-drug | 1.0 | — | No fix listed | CNA |
- db-hospital-drug VendorJamesZBL Affected 1.0 Fixed in — No fix listed CNA
- db-hospital-drug Vendorcode-projects Affected 1.0 Fixed in — No fix listed CNA
Remediation
No fixed version listed by the sources yet.
Timeline
- 2026-10-02 Threatist record created from CVE-2025-3569
- 2026-10-03 Alias added: GHSA-6vrq-h789-6x32
References
More JamesZBL Db-hospital-drug vulnerabilities
- TI-2025-03139 JamesZBL/code-projects db-hospital-drug ContentController.java save cross site scripting CVSS 4.0MEDIUM 5.1
Sources
- CVE-2025-3569 · CVE Program
- CVE-2025-3569 · NVD
- FIRST EPSS
- GHSA-6vrq-h789-6x32 · GitHub Advisory Database · CC BY 4.0
This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences